Company intelligence / Profile preview

Myconeos

Nottingham, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Myconeos has achieved significant breakthroughs by enabling sexual breeding in previously asexual Penicillium fungi, resulting in hundreds of novel strains used in cheese and vegan cheese fermentation, plus applications in natural colorants, fermented meats, and bioremediation. Their technology is commercial with ongoing program innovation and expansion into new fungal species.

Therapeutic areas: Other
Modalities: Microbial therapyEnzymeNatural colorant producer
Industry: Non-Drug Biotech

Partnerships

Formo (precision fermentation company, Germany)VBites (UK plant food company)

Beyond the preview

Go deeper on Myconeos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myconeos.

Explore the full profile